Glutathione MRI Mapping for Mitochondrial Dysfunction Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for imaging glutathione deficiency and mitochondrial dysfunction are complex and inaccurate due to overlap with other metabolites, and there is a lack of documented techniques for using glutathione-enhancing interventions to map these conditions.
Innovation Solution
Administer glutathione or glutathione-increasing interventions, such as oral liposomal reduced glutathione, and use magnetic resonance imaging to map glutathione uptake, converting it into an increase in uptake to highlight depleted areas, serving as a biomarker for mitochondrial dysfunction and health risk.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If magnetic resonance spectroscopy is used to measure glutathione in single voxels, then measurement is feasible, but mapping accuracy is insufficient due to overlap with other metabolites
Solution Approach 1:
The patent uses an edited spectroscopic sequence with frequency-selective pulses as an intermediary mechanism to isolate the glutathione signal from overlapping metabolites. The MEGA-PRESS sequence applies editing pulses at specific frequencies (e.g., 1.85 ppm for GSH) to selectively detect glutathione while suppressing signals from other metabolites like NAA and creatine, thereby resolving the signal overlap problem without requiring completely new imaging equipment
Solution Approach 2:
The patent changes multiple spectroscopic parameters including spectral width, frequency offsets, pulse durations, and echo times to optimize glutathione detection. By adjusting the spectral width to cover the glutathione region (1.0-2.5 ppm) and setting appropriate frequency offsets for editing pulses, the method enhances glutathione signal specificity while maintaining compatibility with standard clinical MRI scanners
2Area of stationary object
If glutathione levels are measured in multiple brain regions, then mapping coverage is improved, but measurement time increases significantly
Solution Approach 1:
The patent divides the brain into multiple discrete regions of interest (ROIs) including frontal cortex, temporal cortex, parietal cortex, occipital cortex, and subcortical structures. Each ROI is assigned specific frequency ranges for spectroscopic analysis, allowing parallel processing of multiple brain regions through segmented spectral analysis rather than sequential scanning
Solution Approach 2:
The method uses a reduced spectral width (1.0-2.5 ppm) focused specifically on the glutathione frequency range, rather than analyzing the entire metabolic spectrum. This partial action approach concentrates measurement resources on the critical glutathione signal while accepting that other metabolites outside this range are not measured, thereby reducing total measurement time
3Measurement precision
If glutathione is administered to enhance uptake mapping, then detection sensitivity improves, but baseline variability across individuals complicates interpretation
Solution Approach 1:
The patent performs baseline glutathione measurements in multiple brain regions before administering glutathione supplementation. These baseline values are stored and used for comparison with post-supplementation measurements, allowing individual-specific baseline correction that accounts for natural variability in glutathione levels across different people and brain regions
Solution Approach 2:
The method uses the measured baseline glutathione levels as feedback to interpret the effectiveness of supplementation. By comparing post-intervention glutathione levels against the individual's own baseline, the system provides feedback on whether the supplementation has successfully increased glutathione levels in specific brain regions, enabling personalized assessment of treatment response
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Provides accurate mapping of glutathione deficiency and mitochondrial dysfunction, enabling personalized treatment strategies and early detection of health risks, overcoming variability in baseline glutathione levels and enhancing treatment efficacy.
Implementation Method 1
Liposomes are capable of crossing the blood brain barrier
Implementation Method 2
Liposomes are capable of crossing the blood brain barrier
Implementation Method 3
Glutathione can be reliably and repeatably measured in vivo using magnetic resonance spectroscopy
Data Source
AI summary
The disclosed invention is a method for mapping glutathione deficiency and/or mitochondria dysfunction in disease states, utilizing glutathione and its precursors as imaging tracers in conjunction with medical imaging techniques, particularly magnetic resonance imaging. The innovation involves administering glutathione or glutathione-increasing interventions, such as oral liposomal reduced glutathione, to enhance imaging accuracy. The proposed methodology aims to identify and monitor regions of depleted reduced glutathione (GSH) in various organs and tissues. The maps generated through this process provide valuable biomarkers for toxic exposure, early biological effects, and health risks. The approach is versatile, offering applications in mental health, neurological disorders, inflammation, organ dysfunction, and personalized treatment and risk assessments.